Why the study?
LAA occlusion is contraindicated in patients with LAA thrombus due to the risk of procedural clot dislodgement and systemic embolization, though isoproterenol and carotid filter placement may offer solutions.
Does upfront isoproterenol infusion and prophylactic carotid filter placement allow safe LAA occlusion in a patient with recurrent LAA thrombus?
Case Report (n=1)
No
Does upfront isoproterenol infusion and prophylactic carotid filter placement allow safe LAA occlusion in a patient with recurrent LAA thrombus?
Upfront isoproterenol infusion and prophylactic carotid filter placement may facilitate safe LAA occlusion in high-risk patients with apparent LAA thrombus.
Answers are grounded in this paper and cite their sources.
May enable LAAO in select high-risk cases; hypothesis-generating and requires prospective validation before adoption.
Left atrial appendage (LAA) occlusion with the Watchman™ device (Boston Scientific, Marlborough, MA) is indicated in patients with a long-term contraindication to anticoagulation and need for stroke prophylaxis. However, the procedure is contraindicated in patients with LAA thrombus to avoid the risk of systemic embolization from clot dislodgement caused by procedural manipulation. Case reports have described spontaneous echo contrast clearing with isoproterenol.1,2 Also, studies from a transaortic valve replacement population have demonstrated the feasibility of carotid filter placement for cerebral protection in interventional cardiac procedures.
No takes yet. Share an insight, caveat, or question.
Lador et al. (2021) conducted a case report in Atrial fibrillation with recurrent left atrial appendage thrombus (n=1). Isoproterenol infusion and carotid filter placement was evaluated on Resolution of LAA thrombus appearance and successful device implantation without neurological sequelae.
Synapse has enriched 10 related papers. Consider them for comparative context: